
At Consytel ® Life Sciences, we are redefining allergy diagnostics with a focus on point-of-care testing and in-vitro allergen detection. Allergies affect millions in India, often misdiagnosed or treated symptomatically due to delayed or inaccessible testing. Our innovative approach addresses this gap with a rapid, accurate, and accessible solution for IgE-mediated allergic conditions such as allergic rhinitis, asthma, and eczema.
Our upcoming bedside allergy detection kit is designed to identify up to 100 Indian-specific allergens within 20 minutes, using just a few drops of blood — a breakthrough in rapid allergy testing. This enables primary care physicians to make timely, evidence-based decisions, reducing unnecessary chronic medication and improving patient outcomes.
Key Features of Our Allergy Diagnostic Platform:
🧬 Rapid In-Vitro Allergy Test Kit: Detects up to 100 allergens in under 20 minutes at room temperature.
🩸 Minimal Sample Requirement: Requires only a few drops of blood for accurate IgE detection.
🇮🇳 Indian Allergen Panel: Custom-developed using locally extracted allergens for higher diagnostic accuracy.
🏥 Point-of-Care Ready: Designed for use in clinics, hospitals, and primary care settings.
⏱️ Faster Than Traditional Lab Tests: Eliminates 72–96 hour lab turnaround times.
💡 Empowers Primary Care Physicians: Enables immediate diagnosis and personalized allergy management.
🌍 Scalable for Mass Screening: Ideal for underserved populations and rural healthcare outreach.













